Monte Rosa Therapeutics, Inc.
Ticker: 1826457
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
54.37
+506.1%+325.8%
Expenditure
56.31
-3.1%+23.1%
Net Profit
3.06
+107.1%+111.3%
OPM %
-3.57%
+96.43pp+96.43pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingGLUE
202611Jun
Board Meeting
Annual Meeting of Stockholders to elect three Class II direc…
SEC Filing ↗